about
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsySolution-phase parallel synthesis of novel 1,2,3,4-tetrahydroisoquinoline-1-ones as anticonvulsant agents.Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reports.Unilateral and Bilateral Cortical Resection: Effects on Spike-Wave Discharges in a Genetic Absence Epilepsy Model.Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysisPharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis.Corticosteroid-related central nervous system side effects.Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions.Skin rash during treatment with generic itraconazole.Anticonvulsive Activity in Audiogenic DBA/2 Mice of 1,4-Benzodiazepines and 1,5-Benzodiazepines with Different Activities at Cerebellar Granule Cell GABAA Receptors.Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy.Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model.Solution-phase parallel synthesis and evaluation of anticonvulsant activity of N-substituted-3,4-dihydroisoquinoline-2(1H)-carboxamides.
P50
Q28280535-39158B67-85F2-4407-A99B-CAF408F4155EQ33317745-2B768AE1-869F-4B80-A956-3A652CED2054Q34360600-18FD123B-CEB8-4A53-A300-AA8B942C4BFDQ35069100-E6876F63-9672-4AFE-BA81-4D708EF8AE11Q35742532-8D5235F7-29C0-4B89-8957-D4C3D1293486Q36969387-C6C9E8B8-0EF8-45C8-AEC9-01EF627A6F9FQ37369659-D133460C-0D53-47A6-ACFD-ACC7C240CCC7Q37369685-A7E065EB-3348-42FE-8B28-4CFEDD3C8868Q38435137-47A2E26A-D665-415D-853E-44B0FB4107FAQ39186600-98EA7106-6CA5-44E1-AD4C-A728DF18A36FQ39389234-5CFFF469-11A9-4A4F-8C13-D66292367FD0Q43240417-F9D8DA3D-E49E-468C-AAA5-836F878B702DQ44829751-565B721E-38E0-4AB2-B703-279873478B79Q46649514-2D5EB9A8-5F6B-46BB-9889-D86C54677E5A
P50
name
Francesca Scicchitano
@ast
Francesca Scicchitano
@en
Francesca Scicchitano
@es
Francesca Scicchitano
@nl
type
label
Francesca Scicchitano
@ast
Francesca Scicchitano
@en
Francesca Scicchitano
@es
Francesca Scicchitano
@nl
prefLabel
Francesca Scicchitano
@ast
Francesca Scicchitano
@en
Francesca Scicchitano
@es
Francesca Scicchitano
@nl